Recent Headlines
Within Chemical Manufacturing
Careington Proud to Sponsor 13th Annual Dr. Martin Luther King Jr. Essay and Oration Scholarship Competition
Careington is proud to have served another year as a "Dream" level sponsor for the 13th annual Dr. Martin Luther King Jr. Essay and Oration Scholarship competition. This annual event is hosted by Linking Cultures of Frisco, a Frisco-based non-profit organization with a mission to connect... - January 29, 2023 - Careington
Alpyne Strategy’s Elizabeth Ortlieb to Host Refrigerant Briefing at AHR Expo
Alpyne Strategy's Co-Founder & Director Elizabeth Ortlieb is a featured speaker (podcaster) at the world's largest HVAC-R expo, which is taking place Feb 6-8 in Atlanta, GA, at the Georgia World Congress Center. - January 29, 2023 - Alpyne Strategy
AMPP Appoints New Board Member
The Association for Materials Protection and Performance (AMPP), a global nonprofit representing corrosion and coatings professionals and industry, announces the appointment of Steven Meyers to the board of directors. His one-year non-voting term began on January 1, 2023. “The mission of... - January 25, 2023 - AMPP
Razor Agile – a GIT Integrated Software Development Solution for Windows or Linux
Deliver quality software while cutting your time-to-value and time-to-market with Razor. Razor by Visible Systems Corporation provides full automation, accountability, and enforcement of your software development process. Compliant with NIST 800-53 and ISO 27002 – all activity is maintained... - January 23, 2023 - Visible Systems
David Joseph Joins XeroThera as President
XeroThera, Inc, a privately held biomaterials and med tech company, developing breakthrough technologies for tissue engineering and the controlled and targeted delivery of drugs and biological molecules, today announced that David S. Joseph has joined the company as President. He is also joining... - January 18, 2023 - XeroThera
Genesis AEC Celebrates 25th Anniversary
Leading AEC firm’s milestone includes 8,300+ projects for 600+ life sciences leaders nationwide. - January 18, 2023 - Genesis AEC
Newly Available Horse-Side IgG Test Requires No Refrigeration
VMRD, Inc is excited to share the launch of their latest offering for equine veterinarians, a novel horse-side test to measure IgG in foals. - January 17, 2023 - VMRD, Inc.
NooIQ™: Premium "Min-Stim" Nootropic Adaptogen Supplement Stack for Memory and Learning
NooIQ™ is a premium nootropic multi-supplement capsule based on an exhaustive literature review and 7 years of rigorous R&D. Ingredients such as Choline (CDP and Bitartrate) and Magnesium (Citrate and L-threonate) are often associated with improved memory and learning. Others such as L-theanine support concentration and focus while avoiding the excess stimulants found in nervous-energy producing products such as energy shots, as per the manufacturer's minimally-stimulant ("Min-Stim") philosophy. - January 14, 2023 - Integrity Nootropics
H.J. Baker Promotes Angel Sanchez to CFO
H.J. Baker & Bro., LLC is pleased to announce the promotion of Angel Sanchez to Chief Financial Officer. “We are thrilled to promote Angel to CFO. He proved to be an excellent candidate during our search and has been invaluable as an interim,” said President and COO Luis Masroua. - January 12, 2023 - H.J. Baker & Bro., LLC
Huntington Study Group Names First Chief Innovation Officer
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, today announced Brett Kinsler has been named to the newly created position of Chief Innovation Officer (CINO). - January 10, 2023 - Huntington Study Group
Alpyne Strategy Wins Award for Best Social Media Marketing in Murfreesboro, TN
Expertise.com, a national directory for local businesses, awarded Alpyne Strategy for being among the best social media marketing agencies in Murfreesboro, TN. Using its own objective rating system, Expertise.com evaluated nearly 30 Murfreesboro social media marketing agencies on more than 25... - January 08, 2023 - Alpyne Strategy
David Roh Joins AeroGo, Inc. as Western Regional Sales Manager
AeroGo, Inc. is pleased to announce that David Roh has joined the firm as Western Regional Sales Manager. David will manage business relationships and dealer development throughout the western half of the United States and Canada. David will focus on flexible manufacturing solutions and provide... - January 03, 2023 - AeroGo, Inc.
Nisha Johari, MD & Co-Founder, JDHL Featured as "Most Influential Business-Woman of the Year 2022"
Mrs Nisha Johari, MD & Co-founder of Johari Digital Healthcare Ltd. has been featured as "The Most Influential Business Women of the Year 2022,” by The CEO Magazine. - December 31, 2022 - Johari Digital Healthcare Ltd.
BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications
BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications. - December 30, 2022 - BOC Sciences
The Catholic Children’s Home Receives a Christmas Surprise
ProCare Health Embraces the Gift of Giving - December 23, 2022 - ProCare Health
Paras Biopharmaceuticals Creates Excellence with “Continuous Biomanufacturing”: Achieves Objectives of “High Productivity & Biomanufacturing Innovation”
With 6 years of dedicated work at Paras Biopharmaceuticals and the use of Paras Biopharmaceuticals’ unique technology platform (which comprises of Bioproduction technologies for economical production of biologics), the company is pleased to announce that an excellent scale-up production process is achieved with “Continuous Biomanufacturing.” - December 19, 2022 - Paras Biopharmaceuticals Finland Oy
Solex Thermal Science Commits to UN Global Compact
New report illustrates progress on sustainability development goals. - December 17, 2022 - Solex Thermal Science
Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”
Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and capabilities (this division is now referred to as Paras Biopharma), the creation of Paras Biologics enhances the company’s biologics and biosimilar pipeline for co-development and licensing opportunities. - December 11, 2022 - Paras Biopharmaceuticals Finland Oy
Black Forest Ham Specialities Stay Fresh Longer Thanks to Modern Vacuum Packaging by Busch Vacuum Solutions
In 2021, the central vacuum system was due to be expanded. Consumer demand has increased significantly and more and more packaging machines have been used at Schwarzwaldhof. As a result, the demand for vacuum also increased. The new system consists of MINK claw vacuum pumps, COBRA screw vacuum pumps and PANDA vacuum boosters. - December 11, 2022 - Busch Vacuum Solutions
PharmStars Announces Fall 2022 Accelerator Graduates: 11 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Fall 2022 program focused on “Innovations in Real-World Evidence.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week education, and mentoring program. PharmaU culminated with a Showcase Event--held in Boston in early November--that brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - December 08, 2022 - PharmStars
IVL Creates New Supplement for Optimized Nitric Oxide Support and Better Blood Flow
4 ingredients to support the body's production of Nitric Oxide, a vital molecule for maintaining healthy muscles and blood vessels. - December 08, 2022 - IVL.com
PharmStars Announces “Innovations in Women’s Health and Health Equity” Theme for Spring 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its Spring 2023 cohort with the theme “Digital Innovations in Women’s Health and Health Equity.” Startups with digital innovations that promote more equitable, inclusive healthcare for underserved population or focused on women’s health (e.g., breast, ovarian, and cervical cancer; gynecological conditions; osteoporosis; menopausal, hormonal, and reproductive conditions) are welcome to apply. - December 05, 2022 - PharmStars
Clinical Research Organization, Huntington Study Group “Firsts” Continue
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) through its Clinical Research Organization (CRO), HSG Clinical Research, Inc. (HSGCR) continues making groundbreaking progress in the HD world. At their Annual Meeting in November, the... - December 05, 2022 - Huntington Study Group
Westside Finishing Co., Inc. Achieves PCI 3000 Re-Certification
Westside Finishing Co., Inc. is proud to announce the achievement of PCI 3000 recertification, marking 7 consecutive years of certified status. The PCI 3000 Certification Program, administered by The Powder Coating Institute (PCI), is an extensive audit program that evaluates a custom... - December 02, 2022 - Westside Finishing Inc.
NaturaLawn of America Welcomes New Marketing Director
NaturaLawn® of America is a national lawn care franchise system with 35 owners holding 99 licenses, servicing over 125,000 customers in 26 states welcomes a strategic Director of Marketing. - December 01, 2022 - NaturaLawn of America
Paras Biopharmaceuticals Finland Oy is Highly Recommended for Biologics CDMO – Development / Scale-up & Production of Biologics by Innovative USA Biopharma Company
Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Biopharmaceuticals Team has successfully completed multiple biologics projects in 2022. - November 29, 2022 - Paras Biopharmaceuticals Finland Oy
Huntington Study Group Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD), recently held its 29th Annual Meeting in Tampa, FL. This renowned meeting brings together HD thought leaders, scientific experts, industry partners and sponsors, advocacy groups, and... - November 29, 2022 - Huntington Study Group
David Lim Joins the Team at Microvascular Therapeutics as Director of Finance
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of David Lim as Director of Finance at MVT. Mr. Lim brings a broad experience with the business development and strategic financing for diagnostic pharmaceuticals across all... - November 25, 2022 - Microvascular Therapeutics, Inc.
Marty Rosenberg joins the Board of Scientific Advisors at Microvascular Therapeutics.
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Marty Rosenberg to the MVT Board of Scientific Advisors. Mr. Rosenberg brings a broad experience with the clinical development and global regulatory approval process for... - November 25, 2022 - Microvascular Therapeutics, Inc.
Novugen Pharma Became the First Pharmaceutical Company in Malaysia to Receive USFDA Approval for Its Manufacturing Facility
The Company was audited in September 2022 and USFDA issued an Establishment Inspection Report (EIR) in November 2022. Novugen Pharma is the first USFDA approved pharmaceutical manufacturing in Malaysia and the only in Southeast Asia. - November 22, 2022 - Novugen
Introducing MIRAPeel MD, the Only 6-in-1 Clinical-Grade Skincare Platform of Its Kind
Attention Dermatologists, Plastic Surgeons and Med Spa Owners: Meet MIRAPeel MD, the one stop shop for all skin needs, and the first of its kind. Offering 6 treatments in one, MIRAPeel MD is setting a new treatment standard for skin care specialists, medical spas, dermatology and plastic surgery offices. - November 22, 2022 - eMIRAmed
Immunodominant Announces Call for Initial Investment Round as Company Prepares for Phase 2 Study of Oral OTC COVID-19 Drug
Immunodominant Inc., a drug discovery and development company engaged in progressing innovative research from academia to commercialization, today announced its intention to begin an initial financing round of up to $30 million. Immunodominant also announced today that it is scheduling a Phase 2 clinical study after a pre-IND meeting with the FDA for LACTOVID, a novel, oral, over-the-counter drug for the prevention and treatment of COVID-19. - November 20, 2022 - Immunodominant
Garrison Minerals' Products Now NSF-Certified
Garrison Minerals is excited to announce the formal certification of the AlkapHix®, MaripHix™, and OxipHix® product lines by the National Sanitation Foundation (NSF International) and the American National Standards Institute (ANSI). - November 18, 2022 - Garrison Minerals
Microvascular Therapeutics Receives Funds from the National Cancer Institute (NCI) for Its Brain Tumor Program
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, AZ, was recently awarded a Phase I Small Business Innovation Research grant from the National Cancer Institute (NCI). Emmanuelle Meuillet, Chief Scientific and Operating Officer at MVT said, “We are... - November 18, 2022 - Microvascular Therapeutics, Inc.
Prosel Bioscience Becomes One Cell Foods and Names Dr. Scott Jenkins Its New CEO
One Cell Food, Inc will focus on scaling its proprietary bioreactor design to commercialize developed strains for its first food product by early 2023. As the new CEO, Dr. Scott Jenkins will lead the operation and fundraising efforts. - November 17, 2022 - One Cell Foods, Inc.
DASH Leverages Automated Solutions
Artificial Intelligence Tools Combined with Proven ERP Creates a Powerful Platform for Businesses. - November 17, 2022 - Dash Development
Alpyne Strategy to Host Refrigerant Briefing for Fall 2022
Alpyne Strategy, a leading industrial marketing agency in Murfreesboro, TN, will host a Refrigerant Briefing for Fall 2022 live webinar event on Friday, Dec. 9 at 12:00pm CST. In this 1-hour session, HVAC-R stakeholders can learn the top refrigerant insights from this fall. Topics of discussion... - November 14, 2022 - Alpyne Strategy
Families of World War II Veterans Holds 2022 Fundraising Golf Tournament
Families of World War II Veterans held its annual golf tournament and fundraising event on Monday, October 24, at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This is the organization’s biggest fundraising event... - November 12, 2022 - Careington
Are You Ready to Get Shroomed?
After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed
BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release
BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing a comprehensive set of analysis and characterization technologies. - November 11, 2022 - BOC Sciences
BOC Sciences Makes Easy Access to Polymerization Tech
Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support. - November 11, 2022 - BOC Sciences
PharmStars Announces Fall 2022 Startup Showcase Event
PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars
Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)
Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.
Thrivous Launches Vitality Geroprotector Formula 2
Thrivous, the human enhancement company, has released Vitality Geroprotector Formula 2 with Mirtoselect® Blueberry Anthocyanin. Vitality is the advanced geroprotector supplement that Thrivous develops to enhance metabolism and cell function for better aging. Vitality combines geroprotector... - November 07, 2022 - Thrivous
Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order
Cold Chain system is designed for storage, transportation and dispensary of temperature-sensitive medical therapeutics to eliminate all spoilage in cold-chain logistics and improve patient outcomes - November 03, 2022 - Thaddeus Medical
Beaulieu International Group Acquires Leading US Synthetic Turf Manufacturer Act Global, Strengthening Its Position in the Growing Market for Sports Turf
Through this acquisition, B.I.G. strengthens its position in the global artificial grass market, especially in the sports segment. Act Global has close to 300 certified fields installed and holds soccer (FIFA), hockey (FIH) and rugby (WR) certifications. No financial details are disclosed on the transaction. - November 02, 2022 - Act Global
DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research
CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR
Gallant Announces Hiring of John Klacking, Ph.D. as Chief Business Officer
Furthering its regenerative medicine therapeutics research and development, animal biotech company Gallant welcomes a pioneer in the biotech space. - October 25, 2022 - Gallant
Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group
Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.